Juvenile systemic lupus erythematosus with primary neuropsychiatric presentation

BMJ Case Rep. 2013 Jan 25:2013:bcr2012008270. doi: 10.1136/bcr-2012-008270.

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease with multiple manifestations in several organs and systems. Neuropsychiatric manifestations can occur in 22-95% of paediatric cases, being much less frequent as an initial clinical event. We report a case of SLE, presenting primarily with neuropsychiatric symptoms. An African-descendant 7-year-old girl was admitted with a 4-day history of ataxia, diplopia and morning vomiting, as well as severe headache, psychiatric symptoms and cognitive dysfunction beginning 1 year prior to admission. Brain MRI was suggestive of encephalitis. Investigation excluded infectious aetiology. Immunological markers revealed high titre of antinuclear and anti-double-stranded DNA antibodies. Neuropsychiatric lupus (NPL) was considered, and cyclophosphamide and methylprednisolone pulses were started, with good initial response. Clinical deterioration motivated therapy with azathioprine with subsequent clinical stabilisation and a latent cognitive dysfunction. In unusual encephalitis presentation, a wide range of differential diagnosis has to be considered. Primary NPL presents difficult diagnostic and therapeutic challenges.

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Antinuclear / blood
  • Ataxia / etiology
  • Azathioprine / therapeutic use
  • Child
  • Cognition Disorders / etiology*
  • Cyclophosphamide / therapeutic use
  • Diagnosis, Differential
  • Diplopia / etiology
  • Encephalitis / diagnosis
  • Female
  • Headache / etiology
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Lupus Vasculitis, Central Nervous System / complications
  • Lupus Vasculitis, Central Nervous System / diagnosis*
  • Lupus Vasculitis, Central Nervous System / drug therapy*
  • Mental Disorders / etiology*
  • Methylprednisolone / therapeutic use
  • Vomiting / etiology

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Antinuclear
  • Immunosuppressive Agents
  • Cyclophosphamide
  • Azathioprine
  • Methylprednisolone